A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of 2 chemotherapy drugs called
pemetrexed and gemcitabine might be effective treatment for head and neck squamous cell
cancer. The researchers want to find out what effects, good and/or bad, that this treatment
has on head and neck cancer.